Cargando…
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
BACKGROUND: Routine measurement of tumor markers is not recommended in daily clinical practice for patients with cancer of unknown primary (CUP). We evaluated the diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with CUP. METHODS: We retrospectively revie...
Autores principales: | Takamizawa, Shigemasa, Shimoi, Tatsunori, Yoshida, Masayuki, Tokura, Momoko, Yazaki, Shu, Mizoguchi, Chiharu, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Kojima, Yuki, Sumiyoshi-Okuma, Hitomi, Nishikawa, Tadaaki, Noguchi, Emi, Sudo, Kazuki, Yonemori, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011955/ https://www.ncbi.nlm.nih.gov/pubmed/35421961 http://dx.doi.org/10.1186/s12885-022-09514-3 |
Ejemplares similares
-
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
por: Watanabe, Sho, et al.
Publicado: (2023) -
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022) -
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
por: Kojima, Yuki, et al.
Publicado: (2023) -
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023) -
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)